Home
Scholarly Works
Efficacy and safety of the sublingual bacterial...
Conference

Efficacy and safety of the sublingual bacterial vaccine MV140 in women with recurrent urinary tract infections: An European phase III, multicentre, randomized, double-blind, placebo-controlled trial

Authors

Lorenzo Gomez MF; Foley S; Nickel JC; Padilla-Fernandez BY; Gonzalez-Casado I; Martinez-Huelamo M; Yang B; Saz-Leal P; Casanovas M; Garcia-Cenador MB

Volume

79

Pagination

pp. S188-S188

Publisher

ELSEVIER

Publication Date

June 1, 2021

Conference proceedings

EUROPEAN UROLOGY

ISSN

0302-2838

Labels

Fields of Research (FoR)

Contact the Experts team